These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 22304236)

  • 1. Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.
    Mun J; Jabbar AA; Devi NS; Yin S; Wang Y; Tan C; Culver D; Snyder JP; Van Meir EG; Goodman MM
    J Med Chem; 2012 Aug; 55(15):6738-50. PubMed ID: 22746274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteroaromatization of Coumarin Part I: Design, Synthesis, Reactions, Antitumor Activities of Novel Pyridine and Naphthyridine Derivatives.
    Borik RMA; El-Wahab AHFA
    Curr Org Synth; 2024; 21(4):571-581. PubMed ID: 38174438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one and 3-hydroxy-6H-benzo[c]chromen-6-one act as on-off selective fluorescent sensors for Iron (III) under in vitro and ex vivo conditions.
    Shukur K; Fallah A; Terali K; Kalkan R; Gazi M; Gülcan HO
    Turk J Chem; 2021; 45(3):858-867. PubMed ID: 34385872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural product-inspired synthesis of coumarin-chalcone hybrids as potential anti-breast cancer agents.
    Alhakamy NA; Saquib M; Sanobar ; Khan MF; Ansari WA; Arif DO; Irfan M; Khan MI; Hussain MK
    Front Pharmacol; 2023; 14():1231450. PubMed ID: 37745072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent synthesis of 3,4-dihydro-2
    Jantrapirom J; Palavong N; Tummatorn J; Thongsornkleeb C; Ruchirawat S
    Org Biomol Chem; 2023 Nov; 21(44):8888-8901. PubMed ID: 37902976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigation of fluorescence and metal interaction properties of racemic 7,8,9,10-tetrahydro-3-hydroxy-4-(1-hydroxyethyl)benzo[c]chromen-6-one.
    Gülcan HO; Shukur KT; Mavideniz A; Sirkecioğlu O; Gazi M
    Turk J Chem; 2022; 46(2):295-301. PubMed ID: 38143480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2
    Lv J; Zhou W; Gan J; Wang C
    J Org Chem; 2024 Apr; 89(7):5181-5188. PubMed ID: 38517737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective one-pot synthesis of 4
    Yu X; Lan W; Li J; Bai H; Qin Z; Fu B
    RSC Adv; 2020 Dec; 10(72):44437-44441. PubMed ID: 35517147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.
    Shi Q; Wada K; Ohkoshi E; Lin L; Huang R; Morris-Natschke SL; Goto M; Lee KH
    Bioorg Med Chem; 2012 Jul; 20(13):4020-31. PubMed ID: 22672984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2341-4. PubMed ID: 21420855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel 7H-benzo [c] [1, 3] dioxolo [4, 5-f] chromen-7-one derivatives with potential anti-tumor activity.
    Zhou S; Huang G
    Bioorg Chem; 2020 Dec; 105():104381. PubMed ID: 33113412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Kim Y; Lee EY; Lee KH
    J Nat Prod; 2012 Mar; 75(3):370-7. PubMed ID: 22304236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):546-9. PubMed ID: 21087859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents.
    Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4085-7. PubMed ID: 20542429
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.